The Exchange is a collection of casual podcast discussions featuring key opinion leaders in our community. If you would like to participate or would like to recommend a podcast guest please email us at bd@biomere.com.
In this webinar, Bella Lear discusses why animals remain key to preclinical research and why, despite aspirations for the complete replacement of animals, they are likely to remain an essential tool of drug discovery. New Approach Methodologies (NAMs) are advancing rapidly, yet in most cases, evaluating the efficacy and toxicity of new medicines still relies on animal testing. This webinar reviews the long history of animal models in science-based medicine, and discusses the future which will include both animal models and NAMs.
In this podcast, Kevin Schwartze highlights the importance of enrichment programs to optimize the health status and behaviors of NHP preclinical models. These programs are critical to ensure reproducible high-quality data are generated from these valuable studies while ensuring adherence to ethical standards outlined by the 3Rs.
In this podcast, Valeriia discusses how Biomere’s comprehensive flow cytometry services deliver high-parameter immune profiling, cell phenotyping, receptor occupancy analysis, functional assays, and more with exceptional precision and sensitivity.
In this podcast, Tia Coleman discusses Biomere’s clinical chemistry services to analyze animal model and client supplied samples. Her group measures hematological and chemical analytes from plasma samples and continuously validates new analytes.
In this podcast, Mandi Clark highlights Biomere’s expanding portfolio of MSD assays to analyze inflammation and disease relevant biomarkers in disease model samples for pharmacology, ADME and toxicology studies. The MSD platform is optimized for multiplex and singleplex analysis using small sample volumes.
In this podcast, Kristin Sapp highlights the key benefits of Biomere’s colony management solutions and expanding portfolio of technical services to develop, breed and maintain mouse colonies. Some of the key benefits include priority scheduling, flexibility and advance reproductive technology capabilities.
In this podcast, Mike Strainic discusses mRNA vaccines, ALS, COVID-19 and Alzheimer’s Disease research as well as the need to have transparency between sponsors and CROs to improve communication and service quality.
In this podcast, Vince Mendenhall discusses his motivation to become a veterinarian and the factors that directed his pathway to laboratory animal science as a renowned surgeon and mentor. Vince discusses advice to young lab animal science vets and concludes with a discussion about intrathecal space as well as new frontiers in preclinical research.
